Letermovir for cytomegalovirus prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation: a single-center experience. (PubMed, Blood Res) - Apr 2, 2026 - "Our data support the feasibility of letermovir prophylaxis in pediatric patients. The optimal dose of letermovir in pediatric patients has not been established. Letermovir, used as secondary prophylaxis in pediatric patients, was well tolerated."
Journal • Acute Graft versus Host Disease • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Immunology • Infectious Disease • Pediatrics • Transplantation
|
|
Chang-Hsueh Wu; Chia-Jui Du; Hsiu-Hao Chang; Meng-Yao Lu; Pai-Lin Tsai; Shiann-Tarng Jou; Shu-Wei Chou; Yung-Li Yang
|